Prevalence and associated factors of healthcare associated infections in Habib Bourguiba university hospital, Sfax, Tunisia, 2024

##plugins.themes.academic_pro.article.main##

Emna Mziou
Maroua Trigui
Zeineb Mallek
Mondher Kasiis

Abstract

Introduction-Aim: Healthcare-associated infections (HCAIs) are a major public health issue due to significant related morbidity, mortality and increased costs. This study aimed to determine the prevalence of HCAI in a Tunisian university hospital in 2024 and to determine its associated factors.


Methods: A point-prevalence study was conducted from 10th to 22nd of June 2024 in Habib-Bourguiba hospital in Sfax-Tunisia. It included all patients hospitalised for a minimum of 48 hours.


Results: Of 227 patients, 40 patients had at least one HCAIs, giving a HCAIs prevalence of 17.6% (95%CI 12.8-22.5). The HCAIs prevalence was 46.7% (95%CI 29.2-65.4)   in ICU (Intensive care units) versus 13.9% (95%CI 8.9-19.6) in non-ICU.


Urinary tract infections (40.6%) were the most common, followed by respiratory tract infections and surgical site infections (both 17.4%). The main identified microorganisms among HCAIs were Pseudomonas Aeruginosa (19.3%), Klebsiella Pneumoniae and Proteus Mirabilis (both 14.8%).


Factors independently associated with having at least one HCAI were admission in ICU (aOR=5.7, 95%CI: 2.4-13.3), obesity (aOR = 4.2, 95%CI: 1.5-12.1), age 60 years and older (aOR=2.7, 95%CI: 1.1-7.4), antibiotic use in the past six months (aOR = 2.5, 95%CI: 1.1-5.7), and the number of days of peripheral venous catheter (aOR = 1.6, 95%CI: 1.1-2.5).


Conclusion: Our study fills a critical gap in the literature on the national and regional levels. It revealed a high prevalence of HCAI in Habib-Bourguiba Hospital compared to similar studies in other regions. We, therefore, recommend setting up operational hospital hygiene programmes for healthcare ..(abstract truncated at 250 words)

Keywords:

Healthcare associated infections, Surveillance, Infection Prevention

##plugins.themes.academic_pro.article.details##

Author Biographies

Emna Mziou, Hospital hygiene department, Habib Bourguiba University Hospital, 3029, Sfax, Tunisia.

Dr. Emna Mziou Médecine Préventive et Communautaire
Service d'hygiène hospitalière - CHU Habib Bourguiba Sfax
Faculté de médecine de Sfax, Tunisie  MediPIET Graduate European Center of Disease Prevention and control, Cohort 2022. ORCID: 0000-0003-2682-406X
Email: dremnamziou@gmail.com
Telephone: +21622208368

Maroua Trigui, Hospital hygiene department, Habib Bourguiba University Hospital, 3029, Sfax, Tunisia.

Dr. Maroua Trigui

University Assistant Professor in Preventive and Community Medicine, Faculty of Medicine of Sfax, Tunisia Hospital Assistant Professor in the Hygiene Department, Member of the IPC Team, Member of the Quality and Risk Management Unit, Habib Bourguiba University Hospital, Sfax, Tunisia 2nd Year PhD Student in Public Health, Faculty of Medicine of Sfax E-mail: trigui_maroua@medecinesfax.org

ORCID: 0000-0002-7741-7950 

Zeineb Mallek, Hospital hygiene department, Habib Bourguiba University Hospital, 3029, Sfax, Tunisia.

Zeineb Mallek, Résident en Médecine préventive et communautaire

Mondher Kasiis, Hospital hygiene department, Habib Bourguiba University Hospital, 3029, Sfax, Tunisia.

Pr Mondher Kassis, 

Head of Hospital hygiene department, Habib Bourguiba University Hospital Sfax

Preventive and community medicine

References

  1. Gidey K, Gidey MT, Hailu BY, Gebreamlak ZB, Niriayo YL. Clinical and economic burden of healthcare-associated infections: A prospective cohort study. PLOS ONE. 2023 Feb 23;18(2):e0282141.
  2. Comité Technique National des Infections Nosocomiales et des Infections Liées Aux Soins. Définition des infections associées aux soins. Paris: Ministère de la santé, de la jeunesse et des sports; 2007 May.
  3. World Health Organization. Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. Geneva: World Health Organization; 2016. 90 p.
  4. European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023. Stockholm: ECDC; 2024.
  5. World Health Organisation. WHO Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals. 2017.
  6. Monegro AF, Muppidi V, Regunath H. Hospital-Acquired Infections. In: StatPearls. StatPearls Publishing; 2023.
  7. Haque M, McKimm J, Sartelli M, Dhingra S, Labricciosa FM, Islam S, et al. Strategies to Prevent Healthcare-Associated Infections: A Narrative Overview. Risk Manag Healthc Policy. 2020 Sep 28;13:1765–80.
  8. Mahjoub M, Bouafia N, Bannour W, Masmoudi T, Bouriga R, Hellali R, et al. Healthcare-associated infections in a tunisian university hospital: From analysis to action. Pan Afr Med J. 2015;20(1).
  9. ANNABI ATTIA T, DHIDAH L, HAMZA R, KIBECH M, LEPOUTRE-TOULEMON A. Première enquête nationale tunisienne de prévalence de l’infection nosocomiale : principaux résultats. Prem Enq Natl Tunis Prévalence Infect Nosocomiale Principaux Résultats. 2007;15(2):144–9.
  10. Salsabil REJAIBI. PRÉVALENCE DE L’ANTIBIOTHERAPIE ET PRINCIPAUX PHÉNOTYPES DE RÉSISTANCE BACTÉRIENNE AUX ANTIBIOTIQUES : RÉSULTATS DE L’ENQUÊTE NATIONALE NOSOTUN 2012. Faculté de médecine de Tunis; 2018.
  11. Ghali H, Ben Cheikh A, Bhiri S, Khefacha S, Latiri HS, Ben Rejeb M. Trends of Healthcare-associated Infections in a Tuinisian University Hospital and Impact of COVID-19 Pandemic. Inq J Med Care Organ Provis Financ. 2021;58:469580211067930.
  12. Nouira M, Maatouk M, Youssef SB, Ennigrou S. Prevalence of health care associated infections and antibiotic use among adult patients: Results of a cross-sectional survey at a tertiary university hospital in Tunisia. 2023 Sep 11;
  13. Ayed HB, Yaich S, Trigui M, Jemaa MB, Hmida MB, Karray R, et al. Prevalence and risk factors of health care-associated infections in a limited resources country: A cross-sectional study. Am J Infect Control. 2019 Aug;47(8):945–50.
  14. Ketata N, Ben Ayed H, Ben Hmida M, Trigui M, Ben Jemaa M, Yaich S, et al. Point prevalence survey of health-care associated infections and their risk factors in the tertiary-care referral hospitals of Southern Tunisia. Infect Dis Health. 2021 Nov;26(4):284–91.
  15. National Healthcare Safety Network. National Healthcare Safety Network (NHSN) Patient Safety Component Manual. CDC, Centers for Disease Control and Prevention; 2024 Jan.
  16. Lahlou L, Bouziane A, Obtel M, Dakhama Y, Belayachi J, Madani N, et al. The burden of healthcare-associated infection in Moroccan hospitals: systematic review and meta-analysis. J Public Health Afr. 2023 Nov 30;14(11):13.
  17. Bennett N, Tanamas SK, James R, Ierano C, Malloy MJ, Watson E, et al. Healthcare-associated infections in long-term care facilities: a systematic review and meta-analysis of point prevalence studies. BMJ Public Health. 2024 May 27;2(1).
  18. Abubakar U, Awaisu A, Khan AH, Alam K. Impact of COVID-19 Pandemic on Healthcare-Associated Infections: A Systematic Review and Meta-Analysis. Antibiotics. 2023 Nov;12(11):1600.
  19. McMullen KM, Smith BA, Rebmann T. Impact of SARS-CoV-2 on hospital acquired infection rates in the United States: Predictions and early results. Am J Infect Control [Internet]. 2020 Nov [cited 2024 Sep 30];48(11):1409–11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329659/
  20. Abubakar U. Point-prevalence survey of hospital acquired infections in three acute care hospitals in Northern Nigeria. Antimicrob Resist Infect Control. 2020 May 11;9(1):63.
  21. Daw MA, Mahamat MH, Wareg SE, El-Bouzedi AH, Ahmed MO. Epidemiological manifestations and impact of healthcare-associated infections in Libyan national hospitals. Antimicrob Resist Infect Control. 2023 Nov 6;12:122.
  22. Abubakar U, Amir O, Rodríguez-Baño J. Healthcare-associated infections in Africa: a systematic review and meta-analysis of point prevalence studies. J Pharm Policy Pract. 2022 Dec 9;15:99.
  23. Alothman A, Al Thaqafi A, Al Ansary A, Zikri A, Fayed A, Khamis F, et al. Prevalence of infections and antimicrobial use in the acute-care hospital setting in the Middle East: Results from the first point-prevalence survey in the region. Int J Infect Dis. 2020 Dec 1;101:249–58.
  24. Mengistu DA, Alemu A, Abdukadir AA, Mohammed Husen A, Ahmed F, Mohammed B, et al. Global Incidence of Surgical Site Infection Among Patients: Systematic Review and Meta-Analysis. Inq J Health Care Organ Provis Financ. 2023 Jan 1;60:00469580231162549.
  25. World Health Organisation. Global antimicrobial resistance surveillance system (GLASS) report. Early implementation 2017–2018 [Internet]. Geneva: WHO; 2018. Available from: https://www.who.int/initiatives/glass
  26. Haddad N, Azouzi F, Ben Chaikh A, Kahloun S, Rania A, Ketta S, et al. Evolution of antimicrobial resistance in departments with high risk of cross infections in Tunisia. Eur J Public Health. 2020 Sep 1;30(Supplement_5):ckaa166.723.
  27. Jamoussi A, Ayed S, Ismail KB, Chtara K, Bouaziz M, Mokline A, et al. The prevalence of healthcare-associated infection in medical intensive care units in tunisia. Results of the multi-centre nosorea1 study. Prévalence des infections associées aux soins en réanimation médicale en Tunisie. Résultats de l’étude multicentrique nosorea. Tunis Med. 2018;96.
  28. Huttunen R, Karppelin M, Syrjänen J. Obesity and nosocomial infections. J Hosp Infect. 2013 Sep;85(1):8–16.
  29. Atamna A, Elis A, Gilady E, Gitter-Azulay L, Bishara J. How obesity impacts outcomes of infectious diseases. Eur J Clin Microbiol Infect Dis. 2017 Mar 1;36(3):585–91.
  30. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.
  31. Lipsitch M, Samore MH. Antimicrobial Use and Antimicrobial Resistance: A Population Perspective. Emerg Infect Dis. 2002 Apr;8(4):347–54.